The Modern Day Contract Manufacturing Organisation – Beyond Cost
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
With the rise of outsourcing pharmaceutical activity it is said that contract manufacturing accounts for 30% of a company’s total manufacturing activity and is currently worth $39bn a year. Although, demand for contract manufacturing is growing, budgets are becoming tighter as we all race to achieve better ROI and manage costs more efficiently. The modern day contract manufacturing organisation (CMO) is now a key strategic partner providing access to new markets, new products, greater capacity and innovative technologies for both small-scale and large scale primary and secondary manufacturing. Ahead of the Global Pharmaceutical Contract Manufacturing Summit, Pharma IQ takes a closer look at global CMO market drivers and restraints and the evolution of the modern day CMO.
Have Your Say
Rate this feature and give us your feedback in the comments section below
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.